Deutsche Bank
GLSI icon

Deutsche Bank’s Greenwich LifeSciences GLSI Stock Holding History

Deutsche Bank’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124K Sell
5,162
-889
-15% -$23.2K ﹤0.01% 3183
2025
Q4 		$127K Sell
6,051
-15,451
-72% -$163K ﹤0.01% 3218
2025
Q3 		$214K Buy
+21,502
New +$243K ﹤0.01% 3033
2022
Q2 		– Sell
-2,192
Closed -$43K – 4198
2022
Q1 		$43K Sell
2,192
-260
-11% -$5.25K ﹤0.01% 3882
2021
Q4 		$60K Buy
2,452
+130
+6% +$4.35K ﹤0.01% 3901
2021
Q3 		$91K Sell
2,322
-74
-3% -$3.09K ﹤0.01% 3935
2021
Q2 		$108K Buy
+2,396
New +$90.6K ﹤0.01% 4108

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Deutsche Bank's GLSI Position: Q1 2026 in Review

Deutsche Bank reduced its Greenwich LifeSciences (GLSI) stake by 15% in Q1 2026, selling an estimated $23.2K and leaving 5,162 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #3183.

Deutsche Bank first reported a position in GLSI in Q2 2021 and has held it in 7 quarters since. The position peaked at $214K in Q3 2025. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Deutsche Bank held 5,162 shares of Greenwich LifeSciences worth $124K as of Q1 2026.
  • Deutsche Bank sold 889 Greenwich LifeSciences shares in Q1 2026, an estimated $23.2K.
  • Greenwich LifeSciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3183 holding.
  • Deutsche Bank first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 7 quarters since.
  • Deutsche Bank's Greenwich LifeSciences position peaked at $214K in Q3 2025.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.